May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...
May 22, 2017 12:11 pm UTC| Business
BRIDGEWATER, N.J., May 22, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating use of its V-Go® Wearable Insulin Delivery Device results in significant savings to the pharmacy...